We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Bioengineered Material Rapidly Stops Bleeding During Surgery in Patients on Blood Thinners

By HospiMedica International staff writers
Posted on 24 Jan 2024
Print article
Image: Blood thinners can put patients at risk of life-threatening bleeding during surgery (Photo courtesy of 123RF)
Image: Blood thinners can put patients at risk of life-threatening bleeding during surgery (Photo courtesy of 123RF)

Anticoagulation and antiplatelet medications like heparin or aspirin, commonly taken by millions worldwide to treat heart attack and stroke, also elevate the risk of potentially fatal bleeding during injuries or surgeries. Globally, over five million people die annually from trauma, with more than a third of these deaths due to uncontrolled bleeding. Now, researchers have created a porous material that significantly absorbs blood and effectively initiates clotting, even in patients on these medications. Remarkably, this new hemostat managed to stop bleeding in an average of about five minutes in cardiac catheterization patients on anticoagulants, marking a substantial improvement from the lengthy traditional compression methods that can take more than two hours.

The research team, led by investigators from Brigham and Women’s Hospital (Boston, MA, USA), developed a more effective hemostat by employing a “rational engineering” approach. They simulated blood flow through various pore structures, drawing inspiration from the lung’s alveoli – spherical air sacs with a large surface area and a complex porous structure that enable efficient blood interaction. This guided them to design their material with a similar intricate, spherical microporous structure, optimizing blood absorption and the accumulation of vital clotting components like platelets.

Chitosan, a substance extracted from shellfish, forms the base of this alveoli-like structure. Already utilized in some hemostats, chitosan’s positive charge effectively attracts negatively charged platelets and fibrinogen, key blood clot components. The researchers discovered an additional benefit: chitosan activates the TLR-2 clotting pathway, directly stimulating clotting even in patients on anticoagulants. When tested on 70 patients undergoing cardiovascular catheterization and on heparin, the material reduced bleeding to an average stoppage time of about five minutes for low-dose heparin patients, and under nine minutes for those on up to 12,500 IU heparin doses.

The chitosan pad simplifies application and removal compared to traditional gauze, which often requires long, strong compression and can be painful and risky to remove. The chitosan hemostat, being more absorptive, can be removed more cleanly and comfortably from wounds. The research team is now exploring further advancements, including studying the wound healing process post-application of the chitosan hemostat and developing next-generation wound dressings capable of drug delivery or enhancing wound cleanliness, potentially reducing the frequency of dressing changes.

“This is a next-generation hemostat that effectively stops bleeding, even in patients who take anticoagulation or antiplatelet medications,” said corresponding author Hae Lin Jang, Ph.D., of the Center for Engineered Therapeutics. “We used an exciting, interdisciplinary approach that combines engineering principles, materials science, and understandings of molecular biology to overcome the limitations of existing therapies and address a real clinical need.”

“This hemostat can save valuable time in emergency situations,” added first author Vivian K. Lee, PhD, of the Center for Engineered Therapeutics. “In emergencies, it can be extremely challenging to screen the prescription information of a patient to provide appropriate anticoagulation reversal therapy to patients on anticoagulants. If a hemostat can bypass a medication’s anticoagulating mechanisms, it can be used in a wide range of patients, saving time, and potentially saving lives.”

Related Links:
Brigham and Women’s Hospital

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Digital Brain Electric Activity Mapping Unit
KT88-2400

Print article

Channels

Critical Care

view channel
Image: Researchers have made significant advances in ingestible microbiome sampling pill technology (Photo courtesy of Tufts University)

Ingestible Microbiome Sampling Pill to Help Diagnose Wide Range of Health Conditions

The healthy human gut is home to more than 1,000 species of bacteria, most of which play a beneficial role in digestion and protecting against disease. When the natural balance of these microbes is disrupted,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.